Companies: 10,795·Total market cap: $144.5T
Apimeds Pharmaceuticals US, Inc

Apimeds Pharmaceuticals US, Inc

APUSAMEXHealthcare● Active
$1.28
+$0.01(+0.79%)
Market Cap$1609725
P/E Ratio—
52W High$40.31
52W Low$1.17
Overview
股票排行：Drug Manufacturers - Specialty & Generic·Healthcare·查看全部市值排行 →

Apimeds Pharmaceuticals US, Inc（APUS）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · APUS · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-6.35apus eps ttm · apus earnings per shareEarnings history
PE Ratio (TTM)—apus pe ratio ttm · apus price to earningsPE Ratio deep dive
Revenue (TTM)0.00apus revenue ttm · apus annual revenueFull revenue history
Dividend Yield不分红does apus pay dividends · apus dividend yieldDividend history
Shares Outstanding10.9Mapus shares outstanding · apus floatShares outstanding history
Next EarningsTBAapus earnings date · apus next earningsEarnings history

探索 Apimeds Pharmaceuticals US, Inc 数据

apus stock data · financials
市值$1.6Mapus market cap · apus valuation
分析师预测—
股息不分红does apimeds pharmaceuticals us, inc pay dividends · apus dividend yield
营收—apimeds pharmaceuticals us, inc annual revenue · apus revenue
盈利EPS $-0.55+54.17%apus earnings · apus eps
市盈率—apus pe ratio · apus price to earnings

财务快照

完整财报
FY 2025Revenue$0.00
202320242025
apimeds pharmaceuticals us, inc revenue · apus revenue 2025
FY 2025Net Income-$6.0M▼ 331.74% YoY
202320242025
apimeds pharmaceuticals us, inc net income · apus profit 2025
FY 2025EPS$-0.55▲ +54.17% YoY
202320242025
apus eps · apimeds pharmaceuticals us, inc earnings per share 2025
TTM:Revenue: $0.00Net Income: -$40.7MEPS: $-6.35View income statement →

股票表现

完整历史
1D+0.79%
1W-12.93%
1M-15.23%
3M-3.76%
YTD-21.95%
1Y-31.91%
5Y-41.82%

关于 Apimeds Pharmaceuticals US, Inc

CEOVinod Menon
IPO DateMay 9, 2025
Employees2
CountryUS
Websiteapimedsus.com

Apimeds Pharmaceuticals US, Inc (APUS) functions as a clinical-stage biopharmaceutical firm operating within the United States. This company is dedicated to the entire lifecycle of its flagship produ…

Drug Manufacturers - Specialty & GenericHealthcareAMEXUS

what is apimeds pharmaceuticals us, inc · apus stock overview · apimeds pharmaceuticals us, inc company profile · who is apimeds pharmaceuticals us, inc ceo · apus AMEX · apimeds pharmaceuticals us, inc headquarters · apimeds pharmaceuticals us, inc business segments

关于股票概览与关键数据

Apimeds Pharmaceuticals US, Inc（APUS）是 Drug Manufacturers - Specialty & Generic 行业的 Healthcare 类公司，于 May 9, 2025 在 AMEX 上市。截至最近交易日，APUS 股价为 $1.28，市值约为 $1.6M。过去12个月累计回报 -31.91%，年初至今回报 -21.95%。

2025 财年 Apimeds Pharmaceuticals US, Inc 营收 —。完整财务数据（营收历史、盈利、资产负债表）请使用上方标签页。

常见问题

截至最近一个交易日，Apimeds Pharmaceuticals US, Inc（APUS）股价为 $1.28，在 AMEX 上市，52周区间为 $1.17 – $40.31。

APUS 最新股价APUS quote todaylive ticker 实时行情
数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议